Literature DB >> 30040916

Therapeutic applications of cannabinoids.

Nancy Maurya1, Bharath Kumar Velmurugan2.   

Abstract

The psychoactive property of cannabinoids is well known and there has been a continuous controversy regarding the usage of these compounds for therapeutic purposes all over the world. Their use for medical and research purposes are restricted in various countries. However, their utility as medications should not be overshadowed by its negative physiological activities. This review article is focused on the therapeutic potential and applications of phytocannabinoids and endocannabinoids. We further highlights their mode of action, overall effects on physiology, various in vitro and in vivo studies that have been done so far and the extent to which these compounds can be useful in different disease conditions such as cancer, Alzheimer's disease, multiple sclerosis, pain, inflammation, glaucoma and many others. Thus, this work is an attempt to make the readers understand the positive implications of these compounds and indicates the significant developments of utilizing cannabinoids as therapeutic agents.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cannabinoids; Endocannabinoids; Phytocannabinoids; Therapeutic agents

Mesh:

Substances:

Year:  2018        PMID: 30040916     DOI: 10.1016/j.cbi.2018.07.018

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  8 in total

1.  Health care provider preferences for, and barriers to, cannabis use in cancer care.

Authors:  A McLennan; M Kerba; U Subnis; T Campbell; L E Carlson
Journal:  Curr Oncol       Date:  2020-05-01       Impact factor: 3.677

Review 2.  The Treatment of Cognitive, Behavioural and Motor Impairments from Brain Injury and Neurodegenerative Diseases through Cannabinoid System Modulation-Evidence from In Vivo Studies.

Authors:  Daniela Calina; Ana Maria Buga; Mihaela Mitroi; Aleksandra Buha; Constantin Caruntu; Cristian Scheau; Abdelhakim Bouyahya; Nasreddine El Omari; Naoual El Menyiy; Anca Oana Docea
Journal:  J Clin Med       Date:  2020-07-27       Impact factor: 4.241

3.  Anti-Inflammatory Effects of Campomanesia xanthocarpa Seed Extract Obtained from Supercritical CO2.

Authors:  Fernanda Petry; Bruna B Dall'Orsoleta; Mikaela Scatolin; Leticia V Morgan; Bianca O Alves; Gabriela S Anzollin; Gabriela A L Zilli; Jaqueline Scapinello; Leticia J Danielli; Krissie D Soares; Miriam Apel; J Vladimir Oliveira; Jacir Dal Magro; Liz G Müller
Journal:  Evid Based Complement Alternat Med       Date:  2021-02-26       Impact factor: 2.629

Review 4.  The Interplay between the Immune and the Endocannabinoid Systems in Cancer.

Authors:  Mariantonia Braile; Simone Marcella; Gianni Marone; Maria Rosaria Galdiero; Gilda Varricchi; Stefania Loffredo
Journal:  Cells       Date:  2021-05-21       Impact factor: 6.600

Review 5.  The Endocannabinoid System: A Target for Cancer Treatment.

Authors:  Chiara Laezza; Cristina Pagano; Giovanna Navarra; Olga Pastorino; Maria Chiara Proto; Donatella Fiore; Chiara Piscopo; Patrizia Gazzerro; Maurizio Bifulco
Journal:  Int J Mol Sci       Date:  2020-01-23       Impact factor: 5.923

Review 6.  A Critical Review of the Role of the Cannabinoid Compounds Δ9-Tetrahydrocannabinol (Δ9-THC) and Cannabidiol (CBD) and their Combination in Multiple Sclerosis Treatment.

Authors:  Éamon Jones; Styliani Vlachou
Journal:  Molecules       Date:  2020-10-25       Impact factor: 4.411

Review 7.  Endocannabinoid System and Tumour Microenvironment: New Intertwined Connections for Anticancer Approaches.

Authors:  Marta Iozzo; Giovanna Sgrignani; Giuseppina Comito; Paola Chiarugi; Elisa Giannoni
Journal:  Cells       Date:  2021-12-02       Impact factor: 6.600

Review 8.  Endocannabinoid Modulation in Neurodegenerative Diseases: In Pursuit of Certainty.

Authors:  Alexandru Vasincu; Răzvan-Nicolae Rusu; Daniela-Carmen Ababei; Mădălina Larion; Walther Bild; Gabriela Dumitrița Stanciu; Carmen Solcan; Veronica Bild
Journal:  Biology (Basel)       Date:  2022-03-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.